Siro Luvisetto

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 12

Top Venues

Toxins

Consiglio Nazionale delle Ricerche

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Consiglio Nazionale delle Ricerche Aug 01 1988

Italy

Researcher :: IBCN - Istituto Biologia Cellulare e Neurobiologia

Publications

Siro Luvisetto
Introduction to the Toxins Special Issue on Botulinum Toxins: New Uses in the Treatment of Diseases. Toxins 15 (9) (2023)
Valentina Mastrorilli, Federica De Angelis, Valentina Vacca, Flaminia Pavone, Siro Luvisetto, Flaminia Pavone
Xeomin ® , a Commercial Formulation of Botulinum Neurotoxin Type A, Promotes Regeneration in a Preclinical Model of Spinal Cord Injury. Toxins 15 (4) (2023)
Valentina Mastrorilli, Federica De Angelis, Valentina Vacca, Flaminia Pavone, Siro Luvisetto, Flaminia Pavone
Xeomin ® , a Commercial Formulation of Botulinum Neurotoxin Type A, Promotes Regeneration in a Preclinical Model of Spinal Cord Injury. Toxins 15 (4) (2023)
Valentina Mastrorilli, Federica De Angelis, Valentina Vacca, Flaminia Pavone, Siro Luvisetto, Flaminia Pavone
Xeomin ® , a Commercial Formulation of Botulinum Neurotoxin Type A, Promotes Regeneration in a Preclinical Model of Spinal Cord Injury. Toxins 15 (4) (2023)
Valentina Mastrorilli, Federica De Angelis, Valentina Vacca, Flaminia Pavone, Siro Luvisetto, Flaminia Pavone
Xeomin ® , a Commercial Formulation of Botulinum Neurotoxin Type A, Promotes Regeneration in a Preclinical Model of Spinal Cord Injury. Toxins 15 (4) (2023)
Valentina Mastrorilli, Federica De Angelis, Valentina Vacca, Flaminia Pavone, Siro Luvisetto, Flaminia Pavone
Xeomin ® , a Commercial Formulation of Botulinum Neurotoxin Type A, Promotes Regeneration in a Preclinical Model of Spinal Cord Injury. Toxins 15 (4) (2023)
Siro Luvisetto
Botulinum Neurotoxins beyond Neurons: Interplay with Glial Cells. Toxins 14 (10) (2022)
Siro Luvisetto
Botulinum Neurotoxins in Central Nervous System: An Overview from Animal Models to Human Therapy. Toxins 13 (11) (2021)
Siro Luvisetto
Botulinum Toxin and Neuronal Regeneration after Traumatic Injury of Central and Peripheral Nervous System. Toxins 12 (7) (2020)
Siro Luvisetto
Introduction to the Toxins Special Issue on Botulinum Neurotoxins in the Nervous System: Future Challenges for Novel Indications. Toxins 12 (9) (2020)
Valentina Vacca, Luca Madaro, Federica De Angelis, Daisy Proietti, Stefano Cobianchi, Tiziana Orsini, Pier Lorenzo Puri, Siro Luvisetto, Flaminia Pavone, Flaminia Pavone
Revealing the Therapeutic Potential of Botulinum Neurotoxin Type A in Counteracting Paralysis and Neuropathic Pain in Spinally Injured Mice. Toxins 12 (8) (2020)
Alba Finocchiaro, Sara Marinelli, Federica De Angelis, Valentina Vacca, Siro Luvisetto, Flaminia Pavone
Botulinum Toxin B Affects Neuropathic Pain but Not Functional Recovery after Peripheral Nerve Injury in a Mouse Model. Toxins 10 (3) (2018)

Siro Luvisetto.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Siro Luvisetto